Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer’s Disease
Condition(s):Alzheimer DiseaseLast Updated:January 8, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Alzheimer DiseaseLast Updated:January 8, 2024Recruiting
Condition(s):Down SyndromeLast Updated:November 8, 2023Recruiting
Condition(s):Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Malignant Neoplasm in the Lung; Metastatic Melanoma; Recurrent Melanoma; Unresectable MelanomaLast Updated:January 12, 2024Not yet recruiting
Condition(s):Transplant-Related Hematologic MalignancyLast Updated:November 8, 2023Recruiting
Condition(s):Breast Adenocarcinoma; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7Last Updated:December 18, 2023Recruiting
Condition(s):Stage III Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7Last Updated:March 27, 2024Recruiting
Condition(s):Lung Non-Squamous Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8Last Updated:January 23, 2024Recruiting
Condition(s):Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Triple-Negative Breast CarcinomaLast Updated:March 25, 2024Recruiting
Condition(s):Advanced Adenocarcinoma; Advanced Malignant Solid Neoplasm; Metastatic Adenocarcinoma; Metastatic Malignant Solid Neoplasm; Recurrent Adenocarcinoma; Recurrent Malignant Solid NeoplasmLast Updated:October 12, 2023Recruiting
Condition(s):NeoplasmsLast Updated:March 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.